Xtant Operating Cycle from 2010 to 2026

XTNT Stock  USD 0.71  0.04  5.33%   
Xtant Medical Operating Cycle yearly trend continues to be comparatively stable with very little volatility. Operating Cycle is likely to outpace its year average in 2026. From the period from 2010 to 2026, Xtant Medical Operating Cycle quarterly data regression had r-value of  0.22 and coefficient of variation of  29.65. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
404.56
Current Value
451.63
Quarterly Volatility
109.57051504
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 141.6 M or Gross Profit of 82.4 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0 or PTB Ratio of 1.51. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Build AI portfolio with Xtant Stock
Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Xtant Medical Holdings over the last few years. It is Xtant Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

Xtant Operating Cycle Regression Statistics

Arithmetic Mean369.53
Geometric Mean344.94
Coefficient Of Variation29.65
Mean Deviation83.88
Median351.79
Standard Deviation109.57
Sample Variance12,006
Range471
R-Value0.22
Mean Square Error12,174
R-Squared0.05
Significance0.39
Slope4.82
Total Sum of Squares192,091

Xtant Operating Cycle History

2026 451.63
2025 404.56
2024 351.79
2023 458.56
2022 312.57
2021 334.87
2020 459.53

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 404.56  451.63 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.